Clay Northam Wealth Management LLC bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 2,595 shares of the company's stock, valued at approximately $235,000.
A number of other hedge funds have also recently modified their holdings of the business. Signaturefd LLC grew its stake in shares of Astera Labs by 112.5% during the second quarter. Signaturefd LLC now owns 850 shares of the company's stock valued at $77,000 after buying an additional 450 shares during the last quarter. Beaumont Financial Advisors LLC bought a new position in shares of Astera Labs during the second quarter valued at approximately $304,000. Wealth Effects LLC bought a new position in shares of Astera Labs during the second quarter valued at approximately $242,000. StoneCrest Wealth Management Inc. grew its stake in shares of Astera Labs by 30.5% during the second quarter. StoneCrest Wealth Management Inc. now owns 6,980 shares of the company's stock valued at $631,000 after buying an additional 1,632 shares during the last quarter. Finally, Public Employees Retirement System of Ohio grew its stake in shares of Astera Labs by 30.9% during the second quarter. Public Employees Retirement System of Ohio now owns 44,459 shares of the company's stock valued at $4,020,000 after buying an additional 10,492 shares during the last quarter. Institutional investors own 60.47% of the company's stock.
Insider Activity at Astera Labs
In other Astera Labs news, Director Jack R. Lazar sold 22,500 shares of the company's stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the completion of the sale, the director owned 97,351 shares in the company, valued at $17,369,365.42. This represents a 18.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Sanjay Gajendra sold 91,441 shares of the company's stock in a transaction on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $16,780,337.91. Following the sale, the chief operating officer owned 2,170,877 shares of the company's stock, valued at approximately $398,377,638.27. This represents a 4.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,576,027 shares of company stock valued at $239,177,011 over the last 90 days. Insiders own 12.50% of the company's stock.
Astera Labs Stock Down 1.4%
Astera Labs stock opened at $197.78 on Friday. The business has a fifty day moving average of $181.88 and a two-hundred day moving average of $114.97. The firm has a market cap of $32.87 billion, a P/E ratio of 353.18, a P/E/G ratio of 5.02 and a beta of 1.48. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90.
Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. The company had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.Astera Labs's revenue was up 149.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.
Analyst Ratings Changes
A number of research analysts have recently commented on the company. Evercore ISI upped their target price on Astera Labs from $104.00 to $215.00 and gave the company an "outperform" rating in a research note on Wednesday, August 6th. Needham & Company LLC increased their price objective on Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Zacks Research raised Astera Labs to a "strong-buy" rating in a research note on Tuesday, August 12th. Stifel Nicolaus set a $145.00 price objective on Astera Labs and gave the stock a "buy" rating in a research note on Monday, August 4th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Astera Labs from $160.00 to $200.00 and gave the stock a "buy" rating in a research note on Tuesday, September 2nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $152.94.
Read Our Latest Stock Analysis on Astera Labs
Astera Labs Profile
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Recommended Stories
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.